TickerFacts.

Vycor Medical Inc (VYCO): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$302.3K
Year ended 2025-12-31
$300.6K
Trailing 12 months to 2026-06-30
+29.1%
3-year compound annual growth
+17.9%
5-year compound annual growth
2010-12-31: $48.7K2011-12-31: $176.3K2012-12-31: $179.5K2013-12-31: $153.8K2014-12-31: $156.3K2015-12-31: $164.1K2016-12-31: $184.7K2017-12-31: $227.1K2018-12-31: $169.6K2019-12-31: $134.8K2020-12-31: $132.5K2021-12-31: $134.7K2022-12-31: $140.6K2023-12-31: $144.9K2024-12-31: $166.8K2025-12-31: $302.3K$302.3K
2010-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$302.3K+81.2%2026-03-31, From 2025-01-01
2024-12-31$166.8K+15.1%2026-03-31, From 2024-01-01
2023-12-31$144.9K+3.1%2025-04-15, From 2023-01-01
2022-12-31$140.6K+4.4%2024-04-16, From 2022-01-01
2021-12-31$134.7K+1.7%2023-04-14, From 2021-01-01
2020-12-31$132.5K-1.7%2022-04-13, From 2020-01-01
2019-12-31$134.8Kn/c2021-03-31, From 2019-01-01
2018-12-31$169.6K-25.3%2020-03-27, From 2018-01-01
2017-12-31$227.1K+23.0%2019-03-29, From 2017-01-01
2016-12-31$184.7K+12.5%2018-03-30, From 2016-01-01
2015-12-31$164.1K+5.0%2017-03-31, From 2015-01-01
2014-12-31$156.3K+1.6%2015-03-31, From 2014-01-01
2013-12-31$153.8K-14.3%2015-03-31, From 2013-01-01
2012-12-31$179.5K+1.9%2014-04-07, From 2012-01-01
2011-12-31$176.3K+261.7%2013-04-01, From 2011-01-01
2010-12-31$48.7Kn/a2012-03-30, From 2010-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Vycor Medical Inc (VYCO)2025-12-31$302.3K+81.2%
EBR Systems, Inc. (NONE.)2025-12-31$1.13Mn/a
Femasys Inc (FEMY)2025-12-31$872.4K+60.1%
QHSLab, Inc. (USAQ)2025-12-31$880.9K+13.8%
SeaStar Medical Holding Corp (ICU)2025-12-31$53.0Kn/a
OSR Health, Inc. (OSRH)2025-12-31$2.31M-14.9%
PetVivo Holdings, Inc. (PETV)2026-03-31$386.9K+181.0%
RenovoRx, Inc. (RNXT)2025-12-31$327.0Kn/a
Nuo Therapeutics, Inc. (AURX)2025-12-31$1.10M+261.8%

Compare VYCO, NONE., FEMY, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗